Global Antihelminthics Market Growth 2025-2031
The global Antihelminthics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Antihelminthics Industry Forecast? looks at past sales and reviews total world Antihelminthics sales in 2024, providing a comprehensive analysis by region and market sector of projected Antihelminthics sales for 2025 through 2031. With Antihelminthics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antihelminthics industry.
This Insight Report provides a comprehensive analysis of the global Antihelminthics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antihelminthics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antihelminthics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antihelminthics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antihelminthics.
This report presents a comprehensive overview, market shares, and growth opportunities of Antihelminthics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Antihelminthics market?
What factors are driving Antihelminthics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antihelminthics market opportunities vary by end market size?
How does Antihelminthics break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Antihelminthics Industry Forecast? looks at past sales and reviews total world Antihelminthics sales in 2024, providing a comprehensive analysis by region and market sector of projected Antihelminthics sales for 2025 through 2031. With Antihelminthics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antihelminthics industry.
This Insight Report provides a comprehensive analysis of the global Antihelminthics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antihelminthics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antihelminthics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antihelminthics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antihelminthics.
This report presents a comprehensive overview, market shares, and growth opportunities of Antihelminthics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Benzimidazoles
- Abamectin
- Salicylanilides
- Praziquantel
- Other
- Schistosomiasis
- Fasciolasis
- Filariasis
- Angiostrongylosis
- Ascariasis
- Giardiasis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Novartis
- ZEISS International
- Johnson & Johnson
- Sanofi
- Merck & Co.
- GlaxoSmithKline
- Astellas Pharma
- Bayer
- Mentis Pharma
- Pfizer
- Sanofi
- ALLERGAN
- AstraZeneca
What is the 10-year outlook for the global Antihelminthics market?
What factors are driving Antihelminthics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antihelminthics market opportunities vary by end market size?
How does Antihelminthics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antihelminthics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antihelminthics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antihelminthics by Country/Region, 2020, 2024 & 2031
2.2 Antihelminthics Segment by Type
2.2.1 Benzimidazoles
2.2.2 Abamectin
2.2.3 Salicylanilides
2.2.4 Praziquantel
2.2.5 Other
2.3 Antihelminthics Sales by Type
2.3.1 Global Antihelminthics Sales Market Share by Type (2020-2025)
2.3.2 Global Antihelminthics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antihelminthics Sale Price by Type (2020-2025)
2.4 Antihelminthics Segment by Application
2.4.1 Schistosomiasis
2.4.2 Fasciolasis
2.4.3 Filariasis
2.4.4 Angiostrongylosis
2.4.5 Ascariasis
2.4.6 Giardiasis
2.4.7 Other
2.5 Antihelminthics Sales by Application
2.5.1 Global Antihelminthics Sale Market Share by Application (2020-2025)
2.5.2 Global Antihelminthics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antihelminthics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antihelminthics Breakdown Data by Company
3.1.1 Global Antihelminthics Annual Sales by Company (2020-2025)
3.1.2 Global Antihelminthics Sales Market Share by Company (2020-2025)
3.2 Global Antihelminthics Annual Revenue by Company (2020-2025)
3.2.1 Global Antihelminthics Revenue by Company (2020-2025)
3.2.2 Global Antihelminthics Revenue Market Share by Company (2020-2025)
3.3 Global Antihelminthics Sale Price by Company
3.4 Key Manufacturers Antihelminthics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antihelminthics Product Location Distribution
3.4.2 Players Antihelminthics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIHELMINTHICS BY GEOGRAPHIC REGION
4.1 World Historic Antihelminthics Market Size by Geographic Region (2020-2025)
4.1.1 Global Antihelminthics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antihelminthics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antihelminthics Market Size by Country/Region (2020-2025)
4.2.1 Global Antihelminthics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antihelminthics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antihelminthics Sales Growth
4.4 APAC Antihelminthics Sales Growth
4.5 Europe Antihelminthics Sales Growth
4.6 Middle East & Africa Antihelminthics Sales Growth
5 AMERICAS
5.1 Americas Antihelminthics Sales by Country
5.1.1 Americas Antihelminthics Sales by Country (2020-2025)
5.1.2 Americas Antihelminthics Revenue by Country (2020-2025)
5.2 Americas Antihelminthics Sales by Type (2020-2025)
5.3 Americas Antihelminthics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antihelminthics Sales by Region
6.1.1 APAC Antihelminthics Sales by Region (2020-2025)
6.1.2 APAC Antihelminthics Revenue by Region (2020-2025)
6.2 APAC Antihelminthics Sales by Type (2020-2025)
6.3 APAC Antihelminthics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antihelminthics by Country
7.1.1 Europe Antihelminthics Sales by Country (2020-2025)
7.1.2 Europe Antihelminthics Revenue by Country (2020-2025)
7.2 Europe Antihelminthics Sales by Type (2020-2025)
7.3 Europe Antihelminthics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antihelminthics by Country
8.1.1 Middle East & Africa Antihelminthics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antihelminthics Revenue by Country (2020-2025)
8.2 Middle East & Africa Antihelminthics Sales by Type (2020-2025)
8.3 Middle East & Africa Antihelminthics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antihelminthics
10.3 Manufacturing Process Analysis of Antihelminthics
10.4 Industry Chain Structure of Antihelminthics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antihelminthics Distributors
11.3 Antihelminthics Customer
12 WORLD FORECAST REVIEW FOR ANTIHELMINTHICS BY GEOGRAPHIC REGION
12.1 Global Antihelminthics Market Size Forecast by Region
12.1.1 Global Antihelminthics Forecast by Region (2026-2031)
12.1.2 Global Antihelminthics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antihelminthics Forecast by Type (2026-2031)
12.7 Global Antihelminthics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Antihelminthics Product Portfolios and Specifications
13.1.3 Abbott Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Antihelminthics Product Portfolios and Specifications
13.2.3 Novartis Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 ZEISS International
13.3.1 ZEISS International Company Information
13.3.2 ZEISS International Antihelminthics Product Portfolios and Specifications
13.3.3 ZEISS International Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ZEISS International Main Business Overview
13.3.5 ZEISS International Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Antihelminthics Product Portfolios and Specifications
13.4.3 Johnson & Johnson Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Antihelminthics Product Portfolios and Specifications
13.5.3 Sanofi Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Merck & Co.
13.6.1 Merck & Co. Company Information
13.6.2 Merck & Co. Antihelminthics Product Portfolios and Specifications
13.6.3 Merck & Co. Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck & Co. Main Business Overview
13.6.5 Merck & Co. Latest Developments
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Information
13.7.2 GlaxoSmithKline Antihelminthics Product Portfolios and Specifications
13.7.3 GlaxoSmithKline Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GlaxoSmithKline Main Business Overview
13.7.5 GlaxoSmithKline Latest Developments
13.8 Astellas Pharma
13.8.1 Astellas Pharma Company Information
13.8.2 Astellas Pharma Antihelminthics Product Portfolios and Specifications
13.8.3 Astellas Pharma Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Astellas Pharma Main Business Overview
13.8.5 Astellas Pharma Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Antihelminthics Product Portfolios and Specifications
13.9.3 Bayer Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Mentis Pharma
13.10.1 Mentis Pharma Company Information
13.10.2 Mentis Pharma Antihelminthics Product Portfolios and Specifications
13.10.3 Mentis Pharma Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mentis Pharma Main Business Overview
13.10.5 Mentis Pharma Latest Developments
13.11 Pfizer
13.11.1 Pfizer Company Information
13.11.2 Pfizer Antihelminthics Product Portfolios and Specifications
13.11.3 Pfizer Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Pfizer Main Business Overview
13.11.5 Pfizer Latest Developments
13.12 Sanofi
13.12.1 Sanofi Company Information
13.12.2 Sanofi Antihelminthics Product Portfolios and Specifications
13.12.3 Sanofi Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sanofi Main Business Overview
13.12.5 Sanofi Latest Developments
13.13 ALLERGAN
13.13.1 ALLERGAN Company Information
13.13.2 ALLERGAN Antihelminthics Product Portfolios and Specifications
13.13.3 ALLERGAN Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 ALLERGAN Main Business Overview
13.13.5 ALLERGAN Latest Developments
13.14 AstraZeneca
13.14.1 AstraZeneca Company Information
13.14.2 AstraZeneca Antihelminthics Product Portfolios and Specifications
13.14.3 AstraZeneca Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 AstraZeneca Main Business Overview
13.14.5 AstraZeneca Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antihelminthics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antihelminthics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antihelminthics by Country/Region, 2020, 2024 & 2031
2.2 Antihelminthics Segment by Type
2.2.1 Benzimidazoles
2.2.2 Abamectin
2.2.3 Salicylanilides
2.2.4 Praziquantel
2.2.5 Other
2.3 Antihelminthics Sales by Type
2.3.1 Global Antihelminthics Sales Market Share by Type (2020-2025)
2.3.2 Global Antihelminthics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antihelminthics Sale Price by Type (2020-2025)
2.4 Antihelminthics Segment by Application
2.4.1 Schistosomiasis
2.4.2 Fasciolasis
2.4.3 Filariasis
2.4.4 Angiostrongylosis
2.4.5 Ascariasis
2.4.6 Giardiasis
2.4.7 Other
2.5 Antihelminthics Sales by Application
2.5.1 Global Antihelminthics Sale Market Share by Application (2020-2025)
2.5.2 Global Antihelminthics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antihelminthics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antihelminthics Breakdown Data by Company
3.1.1 Global Antihelminthics Annual Sales by Company (2020-2025)
3.1.2 Global Antihelminthics Sales Market Share by Company (2020-2025)
3.2 Global Antihelminthics Annual Revenue by Company (2020-2025)
3.2.1 Global Antihelminthics Revenue by Company (2020-2025)
3.2.2 Global Antihelminthics Revenue Market Share by Company (2020-2025)
3.3 Global Antihelminthics Sale Price by Company
3.4 Key Manufacturers Antihelminthics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antihelminthics Product Location Distribution
3.4.2 Players Antihelminthics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIHELMINTHICS BY GEOGRAPHIC REGION
4.1 World Historic Antihelminthics Market Size by Geographic Region (2020-2025)
4.1.1 Global Antihelminthics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antihelminthics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antihelminthics Market Size by Country/Region (2020-2025)
4.2.1 Global Antihelminthics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antihelminthics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antihelminthics Sales Growth
4.4 APAC Antihelminthics Sales Growth
4.5 Europe Antihelminthics Sales Growth
4.6 Middle East & Africa Antihelminthics Sales Growth
5 AMERICAS
5.1 Americas Antihelminthics Sales by Country
5.1.1 Americas Antihelminthics Sales by Country (2020-2025)
5.1.2 Americas Antihelminthics Revenue by Country (2020-2025)
5.2 Americas Antihelminthics Sales by Type (2020-2025)
5.3 Americas Antihelminthics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antihelminthics Sales by Region
6.1.1 APAC Antihelminthics Sales by Region (2020-2025)
6.1.2 APAC Antihelminthics Revenue by Region (2020-2025)
6.2 APAC Antihelminthics Sales by Type (2020-2025)
6.3 APAC Antihelminthics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antihelminthics by Country
7.1.1 Europe Antihelminthics Sales by Country (2020-2025)
7.1.2 Europe Antihelminthics Revenue by Country (2020-2025)
7.2 Europe Antihelminthics Sales by Type (2020-2025)
7.3 Europe Antihelminthics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antihelminthics by Country
8.1.1 Middle East & Africa Antihelminthics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antihelminthics Revenue by Country (2020-2025)
8.2 Middle East & Africa Antihelminthics Sales by Type (2020-2025)
8.3 Middle East & Africa Antihelminthics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antihelminthics
10.3 Manufacturing Process Analysis of Antihelminthics
10.4 Industry Chain Structure of Antihelminthics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antihelminthics Distributors
11.3 Antihelminthics Customer
12 WORLD FORECAST REVIEW FOR ANTIHELMINTHICS BY GEOGRAPHIC REGION
12.1 Global Antihelminthics Market Size Forecast by Region
12.1.1 Global Antihelminthics Forecast by Region (2026-2031)
12.1.2 Global Antihelminthics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antihelminthics Forecast by Type (2026-2031)
12.7 Global Antihelminthics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Antihelminthics Product Portfolios and Specifications
13.1.3 Abbott Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Antihelminthics Product Portfolios and Specifications
13.2.3 Novartis Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 ZEISS International
13.3.1 ZEISS International Company Information
13.3.2 ZEISS International Antihelminthics Product Portfolios and Specifications
13.3.3 ZEISS International Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ZEISS International Main Business Overview
13.3.5 ZEISS International Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Antihelminthics Product Portfolios and Specifications
13.4.3 Johnson & Johnson Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Antihelminthics Product Portfolios and Specifications
13.5.3 Sanofi Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Merck & Co.
13.6.1 Merck & Co. Company Information
13.6.2 Merck & Co. Antihelminthics Product Portfolios and Specifications
13.6.3 Merck & Co. Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck & Co. Main Business Overview
13.6.5 Merck & Co. Latest Developments
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Information
13.7.2 GlaxoSmithKline Antihelminthics Product Portfolios and Specifications
13.7.3 GlaxoSmithKline Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GlaxoSmithKline Main Business Overview
13.7.5 GlaxoSmithKline Latest Developments
13.8 Astellas Pharma
13.8.1 Astellas Pharma Company Information
13.8.2 Astellas Pharma Antihelminthics Product Portfolios and Specifications
13.8.3 Astellas Pharma Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Astellas Pharma Main Business Overview
13.8.5 Astellas Pharma Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Antihelminthics Product Portfolios and Specifications
13.9.3 Bayer Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Mentis Pharma
13.10.1 Mentis Pharma Company Information
13.10.2 Mentis Pharma Antihelminthics Product Portfolios and Specifications
13.10.3 Mentis Pharma Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mentis Pharma Main Business Overview
13.10.5 Mentis Pharma Latest Developments
13.11 Pfizer
13.11.1 Pfizer Company Information
13.11.2 Pfizer Antihelminthics Product Portfolios and Specifications
13.11.3 Pfizer Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Pfizer Main Business Overview
13.11.5 Pfizer Latest Developments
13.12 Sanofi
13.12.1 Sanofi Company Information
13.12.2 Sanofi Antihelminthics Product Portfolios and Specifications
13.12.3 Sanofi Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sanofi Main Business Overview
13.12.5 Sanofi Latest Developments
13.13 ALLERGAN
13.13.1 ALLERGAN Company Information
13.13.2 ALLERGAN Antihelminthics Product Portfolios and Specifications
13.13.3 ALLERGAN Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 ALLERGAN Main Business Overview
13.13.5 ALLERGAN Latest Developments
13.14 AstraZeneca
13.14.1 AstraZeneca Company Information
13.14.2 AstraZeneca Antihelminthics Product Portfolios and Specifications
13.14.3 AstraZeneca Antihelminthics Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 AstraZeneca Main Business Overview
13.14.5 AstraZeneca Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antihelminthics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antihelminthics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Benzimidazoles
Table 4. Major Players of Abamectin
Table 5. Major Players of Salicylanilides
Table 6. Major Players of Praziquantel
Table 7. Major Players of Other
Table 8. Global Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 9. Global Antihelminthics Sales Market Share by Type (2020-2025)
Table 10. Global Antihelminthics Revenue by Type (2020-2025) & ($ million)
Table 11. Global Antihelminthics Revenue Market Share by Type (2020-2025)
Table 12. Global Antihelminthics Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Antihelminthics Sale by Application (2020-2025) & (K Units)
Table 14. Global Antihelminthics Sale Market Share by Application (2020-2025)
Table 15. Global Antihelminthics Revenue by Application (2020-2025) & ($ million)
Table 16. Global Antihelminthics Revenue Market Share by Application (2020-2025)
Table 17. Global Antihelminthics Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Antihelminthics Sales by Company (2020-2025) & (K Units)
Table 19. Global Antihelminthics Sales Market Share by Company (2020-2025)
Table 20. Global Antihelminthics Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Antihelminthics Revenue Market Share by Company (2020-2025)
Table 22. Global Antihelminthics Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Antihelminthics Producing Area Distribution and Sales Area
Table 24. Players Antihelminthics Products Offered
Table 25. Antihelminthics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Antihelminthics Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Antihelminthics Sales Market Share Geographic Region (2020-2025)
Table 30. Global Antihelminthics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Antihelminthics Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Antihelminthics Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Antihelminthics Sales Market Share by Country/Region (2020-2025)
Table 34. Global Antihelminthics Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Antihelminthics Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Antihelminthics Sales by Country (2020-2025) & (K Units)
Table 37. Americas Antihelminthics Sales Market Share by Country (2020-2025)
Table 38. Americas Antihelminthics Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 40. Americas Antihelminthics Sales by Application (2020-2025) & (K Units)
Table 41. APAC Antihelminthics Sales by Region (2020-2025) & (K Units)
Table 42. APAC Antihelminthics Sales Market Share by Region (2020-2025)
Table 43. APAC Antihelminthics Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 45. APAC Antihelminthics Sales by Application (2020-2025) & (K Units)
Table 46. Europe Antihelminthics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Antihelminthics Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 49. Europe Antihelminthics Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Antihelminthics Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Antihelminthics Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Antihelminthics Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Antihelminthics
Table 55. Key Market Challenges & Risks of Antihelminthics
Table 56. Key Industry Trends of Antihelminthics
Table 57. Antihelminthics Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Antihelminthics Distributors List
Table 60. Antihelminthics Customer List
Table 61. Global Antihelminthics Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Antihelminthics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Antihelminthics Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Antihelminthics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Antihelminthics Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Antihelminthics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Antihelminthics Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Antihelminthics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Antihelminthics Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Antihelminthics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Antihelminthics Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Antihelminthics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Antihelminthics Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Antihelminthics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Abbott Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 76. Abbott Antihelminthics Product Portfolios and Specifications
Table 77. Abbott Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Abbott Main Business
Table 79. Abbott Latest Developments
Table 80. Novartis Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Antihelminthics Product Portfolios and Specifications
Table 82. Novartis Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. ZEISS International Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 86. ZEISS International Antihelminthics Product Portfolios and Specifications
Table 87. ZEISS International Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. ZEISS International Main Business
Table 89. ZEISS International Latest Developments
Table 90. Johnson & Johnson Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson Antihelminthics Product Portfolios and Specifications
Table 92. Johnson & Johnson Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. Sanofi Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi Antihelminthics Product Portfolios and Specifications
Table 97. Sanofi Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sanofi Main Business
Table 99. Sanofi Latest Developments
Table 100. Merck & Co. Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck & Co. Antihelminthics Product Portfolios and Specifications
Table 102. Merck & Co. Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Merck & Co. Main Business
Table 104. Merck & Co. Latest Developments
Table 105. GlaxoSmithKline Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 106. GlaxoSmithKline Antihelminthics Product Portfolios and Specifications
Table 107. GlaxoSmithKline Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline Main Business
Table 109. GlaxoSmithKline Latest Developments
Table 110. Astellas Pharma Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 111. Astellas Pharma Antihelminthics Product Portfolios and Specifications
Table 112. Astellas Pharma Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Astellas Pharma Main Business
Table 114. Astellas Pharma Latest Developments
Table 115. Bayer Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer Antihelminthics Product Portfolios and Specifications
Table 117. Bayer Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bayer Main Business
Table 119. Bayer Latest Developments
Table 120. Mentis Pharma Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 121. Mentis Pharma Antihelminthics Product Portfolios and Specifications
Table 122. Mentis Pharma Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Mentis Pharma Main Business
Table 124. Mentis Pharma Latest Developments
Table 125. Pfizer Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 126. Pfizer Antihelminthics Product Portfolios and Specifications
Table 127. Pfizer Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Pfizer Main Business
Table 129. Pfizer Latest Developments
Table 130. Sanofi Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 131. Sanofi Antihelminthics Product Portfolios and Specifications
Table 132. Sanofi Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Sanofi Main Business
Table 134. Sanofi Latest Developments
Table 135. ALLERGAN Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 136. ALLERGAN Antihelminthics Product Portfolios and Specifications
Table 137. ALLERGAN Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. ALLERGAN Main Business
Table 139. ALLERGAN Latest Developments
Table 140. AstraZeneca Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 141. AstraZeneca Antihelminthics Product Portfolios and Specifications
Table 142. AstraZeneca Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. AstraZeneca Main Business
Table 144. AstraZeneca Latest Developments
Table 1. Antihelminthics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antihelminthics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Benzimidazoles
Table 4. Major Players of Abamectin
Table 5. Major Players of Salicylanilides
Table 6. Major Players of Praziquantel
Table 7. Major Players of Other
Table 8. Global Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 9. Global Antihelminthics Sales Market Share by Type (2020-2025)
Table 10. Global Antihelminthics Revenue by Type (2020-2025) & ($ million)
Table 11. Global Antihelminthics Revenue Market Share by Type (2020-2025)
Table 12. Global Antihelminthics Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Antihelminthics Sale by Application (2020-2025) & (K Units)
Table 14. Global Antihelminthics Sale Market Share by Application (2020-2025)
Table 15. Global Antihelminthics Revenue by Application (2020-2025) & ($ million)
Table 16. Global Antihelminthics Revenue Market Share by Application (2020-2025)
Table 17. Global Antihelminthics Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Antihelminthics Sales by Company (2020-2025) & (K Units)
Table 19. Global Antihelminthics Sales Market Share by Company (2020-2025)
Table 20. Global Antihelminthics Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Antihelminthics Revenue Market Share by Company (2020-2025)
Table 22. Global Antihelminthics Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Antihelminthics Producing Area Distribution and Sales Area
Table 24. Players Antihelminthics Products Offered
Table 25. Antihelminthics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Antihelminthics Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Antihelminthics Sales Market Share Geographic Region (2020-2025)
Table 30. Global Antihelminthics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Antihelminthics Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Antihelminthics Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Antihelminthics Sales Market Share by Country/Region (2020-2025)
Table 34. Global Antihelminthics Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Antihelminthics Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Antihelminthics Sales by Country (2020-2025) & (K Units)
Table 37. Americas Antihelminthics Sales Market Share by Country (2020-2025)
Table 38. Americas Antihelminthics Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 40. Americas Antihelminthics Sales by Application (2020-2025) & (K Units)
Table 41. APAC Antihelminthics Sales by Region (2020-2025) & (K Units)
Table 42. APAC Antihelminthics Sales Market Share by Region (2020-2025)
Table 43. APAC Antihelminthics Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 45. APAC Antihelminthics Sales by Application (2020-2025) & (K Units)
Table 46. Europe Antihelminthics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Antihelminthics Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 49. Europe Antihelminthics Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Antihelminthics Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Antihelminthics Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Antihelminthics Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Antihelminthics Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Antihelminthics
Table 55. Key Market Challenges & Risks of Antihelminthics
Table 56. Key Industry Trends of Antihelminthics
Table 57. Antihelminthics Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Antihelminthics Distributors List
Table 60. Antihelminthics Customer List
Table 61. Global Antihelminthics Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Antihelminthics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Antihelminthics Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Antihelminthics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Antihelminthics Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Antihelminthics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Antihelminthics Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Antihelminthics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Antihelminthics Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Antihelminthics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Antihelminthics Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Antihelminthics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Antihelminthics Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Antihelminthics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Abbott Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 76. Abbott Antihelminthics Product Portfolios and Specifications
Table 77. Abbott Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Abbott Main Business
Table 79. Abbott Latest Developments
Table 80. Novartis Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Antihelminthics Product Portfolios and Specifications
Table 82. Novartis Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. ZEISS International Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 86. ZEISS International Antihelminthics Product Portfolios and Specifications
Table 87. ZEISS International Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. ZEISS International Main Business
Table 89. ZEISS International Latest Developments
Table 90. Johnson & Johnson Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson Antihelminthics Product Portfolios and Specifications
Table 92. Johnson & Johnson Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. Sanofi Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi Antihelminthics Product Portfolios and Specifications
Table 97. Sanofi Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sanofi Main Business
Table 99. Sanofi Latest Developments
Table 100. Merck & Co. Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck & Co. Antihelminthics Product Portfolios and Specifications
Table 102. Merck & Co. Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Merck & Co. Main Business
Table 104. Merck & Co. Latest Developments
Table 105. GlaxoSmithKline Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 106. GlaxoSmithKline Antihelminthics Product Portfolios and Specifications
Table 107. GlaxoSmithKline Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline Main Business
Table 109. GlaxoSmithKline Latest Developments
Table 110. Astellas Pharma Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 111. Astellas Pharma Antihelminthics Product Portfolios and Specifications
Table 112. Astellas Pharma Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Astellas Pharma Main Business
Table 114. Astellas Pharma Latest Developments
Table 115. Bayer Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer Antihelminthics Product Portfolios and Specifications
Table 117. Bayer Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bayer Main Business
Table 119. Bayer Latest Developments
Table 120. Mentis Pharma Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 121. Mentis Pharma Antihelminthics Product Portfolios and Specifications
Table 122. Mentis Pharma Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Mentis Pharma Main Business
Table 124. Mentis Pharma Latest Developments
Table 125. Pfizer Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 126. Pfizer Antihelminthics Product Portfolios and Specifications
Table 127. Pfizer Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Pfizer Main Business
Table 129. Pfizer Latest Developments
Table 130. Sanofi Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 131. Sanofi Antihelminthics Product Portfolios and Specifications
Table 132. Sanofi Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Sanofi Main Business
Table 134. Sanofi Latest Developments
Table 135. ALLERGAN Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 136. ALLERGAN Antihelminthics Product Portfolios and Specifications
Table 137. ALLERGAN Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. ALLERGAN Main Business
Table 139. ALLERGAN Latest Developments
Table 140. AstraZeneca Basic Information, Antihelminthics Manufacturing Base, Sales Area and Its Competitors
Table 141. AstraZeneca Antihelminthics Product Portfolios and Specifications
Table 142. AstraZeneca Antihelminthics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. AstraZeneca Main Business
Table 144. AstraZeneca Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antihelminthics
Figure 2. Antihelminthics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antihelminthics Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Antihelminthics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antihelminthics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antihelminthics Sales Market Share by Country/Region (2024)
Figure 10. Antihelminthics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Benzimidazoles
Figure 12. Product Picture of Abamectin
Figure 13. Product Picture of Salicylanilides
Figure 14. Product Picture of Praziquantel
Figure 15. Product Picture of Other
Figure 16. Global Antihelminthics Sales Market Share by Type in 2025
Figure 17. Global Antihelminthics Revenue Market Share by Type (2020-2025)
Figure 18. Antihelminthics Consumed in Schistosomiasis
Figure 19. Global Antihelminthics Market: Schistosomiasis (2020-2025) & (K Units)
Figure 20. Antihelminthics Consumed in Fasciolasis
Figure 21. Global Antihelminthics Market: Fasciolasis (2020-2025) & (K Units)
Figure 22. Antihelminthics Consumed in Filariasis
Figure 23. Global Antihelminthics Market: Filariasis (2020-2025) & (K Units)
Figure 24. Antihelminthics Consumed in Angiostrongylosis
Figure 25. Global Antihelminthics Market: Angiostrongylosis (2020-2025) & (K Units)
Figure 26. Antihelminthics Consumed in Ascariasis
Figure 27. Global Antihelminthics Market: Ascariasis (2020-2025) & (K Units)
Figure 28. Antihelminthics Consumed in Giardiasis
Figure 29. Global Antihelminthics Market: Giardiasis (2020-2025) & (K Units)
Figure 30. Antihelminthics Consumed in Other
Figure 31. Global Antihelminthics Market: Other (2020-2025) & (K Units)
Figure 32. Global Antihelminthics Sale Market Share by Application (2024)
Figure 33. Global Antihelminthics Revenue Market Share by Application in 2025
Figure 34. Antihelminthics Sales by Company in 2025 (K Units)
Figure 35. Global Antihelminthics Sales Market Share by Company in 2025
Figure 36. Antihelminthics Revenue by Company in 2025 ($ millions)
Figure 37. Global Antihelminthics Revenue Market Share by Company in 2025
Figure 38. Global Antihelminthics Sales Market Share by Geographic Region (2020-2025)
Figure 39. Global Antihelminthics Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Antihelminthics Sales 2020-2025 (K Units)
Figure 41. Americas Antihelminthics Revenue 2020-2025 ($ millions)
Figure 42. APAC Antihelminthics Sales 2020-2025 (K Units)
Figure 43. APAC Antihelminthics Revenue 2020-2025 ($ millions)
Figure 44. Europe Antihelminthics Sales 2020-2025 (K Units)
Figure 45. Europe Antihelminthics Revenue 2020-2025 ($ millions)
Figure 46. Middle East & Africa Antihelminthics Sales 2020-2025 (K Units)
Figure 47. Middle East & Africa Antihelminthics Revenue 2020-2025 ($ millions)
Figure 48. Americas Antihelminthics Sales Market Share by Country in 2025
Figure 49. Americas Antihelminthics Revenue Market Share by Country (2020-2025)
Figure 50. Americas Antihelminthics Sales Market Share by Type (2020-2025)
Figure 51. Americas Antihelminthics Sales Market Share by Application (2020-2025)
Figure 52. United States Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 53. Canada Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 54. Mexico Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 55. Brazil Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 56. APAC Antihelminthics Sales Market Share by Region in 2025
Figure 57. APAC Antihelminthics Revenue Market Share by Region (2020-2025)
Figure 58. APAC Antihelminthics Sales Market Share by Type (2020-2025)
Figure 59. APAC Antihelminthics Sales Market Share by Application (2020-2025)
Figure 60. China Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 61. Japan Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 62. South Korea Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 63. Southeast Asia Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 64. India Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 65. Australia Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 66. China Taiwan Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 67. Europe Antihelminthics Sales Market Share by Country in 2025
Figure 68. Europe Antihelminthics Revenue Market Share by Country (2020-2025)
Figure 69. Europe Antihelminthics Sales Market Share by Type (2020-2025)
Figure 70. Europe Antihelminthics Sales Market Share by Application (2020-2025)
Figure 71. Germany Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 72. France Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 73. UK Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 74. Italy Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 75. Russia Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 76. Middle East & Africa Antihelminthics Sales Market Share by Country (2020-2025)
Figure 77. Middle East & Africa Antihelminthics Sales Market Share by Type (2020-2025)
Figure 78. Middle East & Africa Antihelminthics Sales Market Share by Application (2020-2025)
Figure 79. Egypt Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 80. South Africa Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 81. Israel Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 82. Turkey Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 83. GCC Countries Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Antihelminthics in 2025
Figure 85. Manufacturing Process Analysis of Antihelminthics
Figure 86. Industry Chain Structure of Antihelminthics
Figure 87. Channels of Distribution
Figure 88. Global Antihelminthics Sales Market Forecast by Region (2026-2031)
Figure 89. Global Antihelminthics Revenue Market Share Forecast by Region (2026-2031)
Figure 90. Global Antihelminthics Sales Market Share Forecast by Type (2026-2031)
Figure 91. Global Antihelminthics Revenue Market Share Forecast by Type (2026-2031)
Figure 92. Global Antihelminthics Sales Market Share Forecast by Application (2026-2031)
Figure 93. Global Antihelminthics Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Antihelminthics
Figure 2. Antihelminthics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antihelminthics Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Antihelminthics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antihelminthics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antihelminthics Sales Market Share by Country/Region (2024)
Figure 10. Antihelminthics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Benzimidazoles
Figure 12. Product Picture of Abamectin
Figure 13. Product Picture of Salicylanilides
Figure 14. Product Picture of Praziquantel
Figure 15. Product Picture of Other
Figure 16. Global Antihelminthics Sales Market Share by Type in 2025
Figure 17. Global Antihelminthics Revenue Market Share by Type (2020-2025)
Figure 18. Antihelminthics Consumed in Schistosomiasis
Figure 19. Global Antihelminthics Market: Schistosomiasis (2020-2025) & (K Units)
Figure 20. Antihelminthics Consumed in Fasciolasis
Figure 21. Global Antihelminthics Market: Fasciolasis (2020-2025) & (K Units)
Figure 22. Antihelminthics Consumed in Filariasis
Figure 23. Global Antihelminthics Market: Filariasis (2020-2025) & (K Units)
Figure 24. Antihelminthics Consumed in Angiostrongylosis
Figure 25. Global Antihelminthics Market: Angiostrongylosis (2020-2025) & (K Units)
Figure 26. Antihelminthics Consumed in Ascariasis
Figure 27. Global Antihelminthics Market: Ascariasis (2020-2025) & (K Units)
Figure 28. Antihelminthics Consumed in Giardiasis
Figure 29. Global Antihelminthics Market: Giardiasis (2020-2025) & (K Units)
Figure 30. Antihelminthics Consumed in Other
Figure 31. Global Antihelminthics Market: Other (2020-2025) & (K Units)
Figure 32. Global Antihelminthics Sale Market Share by Application (2024)
Figure 33. Global Antihelminthics Revenue Market Share by Application in 2025
Figure 34. Antihelminthics Sales by Company in 2025 (K Units)
Figure 35. Global Antihelminthics Sales Market Share by Company in 2025
Figure 36. Antihelminthics Revenue by Company in 2025 ($ millions)
Figure 37. Global Antihelminthics Revenue Market Share by Company in 2025
Figure 38. Global Antihelminthics Sales Market Share by Geographic Region (2020-2025)
Figure 39. Global Antihelminthics Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Antihelminthics Sales 2020-2025 (K Units)
Figure 41. Americas Antihelminthics Revenue 2020-2025 ($ millions)
Figure 42. APAC Antihelminthics Sales 2020-2025 (K Units)
Figure 43. APAC Antihelminthics Revenue 2020-2025 ($ millions)
Figure 44. Europe Antihelminthics Sales 2020-2025 (K Units)
Figure 45. Europe Antihelminthics Revenue 2020-2025 ($ millions)
Figure 46. Middle East & Africa Antihelminthics Sales 2020-2025 (K Units)
Figure 47. Middle East & Africa Antihelminthics Revenue 2020-2025 ($ millions)
Figure 48. Americas Antihelminthics Sales Market Share by Country in 2025
Figure 49. Americas Antihelminthics Revenue Market Share by Country (2020-2025)
Figure 50. Americas Antihelminthics Sales Market Share by Type (2020-2025)
Figure 51. Americas Antihelminthics Sales Market Share by Application (2020-2025)
Figure 52. United States Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 53. Canada Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 54. Mexico Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 55. Brazil Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 56. APAC Antihelminthics Sales Market Share by Region in 2025
Figure 57. APAC Antihelminthics Revenue Market Share by Region (2020-2025)
Figure 58. APAC Antihelminthics Sales Market Share by Type (2020-2025)
Figure 59. APAC Antihelminthics Sales Market Share by Application (2020-2025)
Figure 60. China Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 61. Japan Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 62. South Korea Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 63. Southeast Asia Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 64. India Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 65. Australia Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 66. China Taiwan Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 67. Europe Antihelminthics Sales Market Share by Country in 2025
Figure 68. Europe Antihelminthics Revenue Market Share by Country (2020-2025)
Figure 69. Europe Antihelminthics Sales Market Share by Type (2020-2025)
Figure 70. Europe Antihelminthics Sales Market Share by Application (2020-2025)
Figure 71. Germany Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 72. France Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 73. UK Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 74. Italy Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 75. Russia Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 76. Middle East & Africa Antihelminthics Sales Market Share by Country (2020-2025)
Figure 77. Middle East & Africa Antihelminthics Sales Market Share by Type (2020-2025)
Figure 78. Middle East & Africa Antihelminthics Sales Market Share by Application (2020-2025)
Figure 79. Egypt Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 80. South Africa Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 81. Israel Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 82. Turkey Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 83. GCC Countries Antihelminthics Revenue Growth 2020-2025 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Antihelminthics in 2025
Figure 85. Manufacturing Process Analysis of Antihelminthics
Figure 86. Industry Chain Structure of Antihelminthics
Figure 87. Channels of Distribution
Figure 88. Global Antihelminthics Sales Market Forecast by Region (2026-2031)
Figure 89. Global Antihelminthics Revenue Market Share Forecast by Region (2026-2031)
Figure 90. Global Antihelminthics Sales Market Share Forecast by Type (2026-2031)
Figure 91. Global Antihelminthics Revenue Market Share Forecast by Type (2026-2031)
Figure 92. Global Antihelminthics Sales Market Share Forecast by Application (2026-2031)
Figure 93. Global Antihelminthics Revenue Market Share Forecast by Application (2026-2031)
